Rate of atherosclerosis progression in ApoE-/- mice long after discontinuation of cola beverage drinking.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3966732)

Published in PLoS One on March 26, 2014

Authors

Matilde Otero-Losada1, Gabriel Cao1, Santiago Mc Loughlin1, Gastón Rodríguez-Granillo1, Graciela Ottaviano1, José Milei1

Author Affiliations

1: Instituto de Investigaciones Cardiológicas, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, ININCA.UBA.CONICET, Buenos Aires, Argentina.

Articles cited by this

Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA (2003) 6.60

Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA (2003) 4.88

Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr (2011) 2.47

Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2001) 1.79

Quantitative image analysis of immunohistochemical stains using a CMYK color model. Diagn Pathol (2007) 1.70

Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2010) 1.35

Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA Study. Atherosclerosis (2008) 1.29

Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging. Lipids Health Dis (2011) 1.22

Nonmuscle myosin light-chain kinase deficiency attenuates atherosclerosis in apolipoprotein E-deficient mice via reduced endothelial barrier dysfunction and monocyte migration. Circulation (2011) 1.14

A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model. Diab Vasc Dis Res (2011) 1.13

Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Atherosclerosis (2008) 1.11

Prevention of overweight/obesity as a strategy to optimize cardiovascular health. Circulation (2011) 1.06

Catechin reduces atherosclerotic lesion development in apo E-deficient mice: a transcriptomic study. Atherosclerosis (2008) 1.02

The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis. Immunobiology (2013) 1.00

Lipid profile and plasma antioxidant status in sweet carbonated beverage-induced metabolic syndrome in rat. Int J Cardiol (2010) 0.95

Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice. Diabetologia (2010) 0.90

Aortic atherosclerotic plaque injury in apolipoprotein E deficient mice. Atherosclerosis (1998) 0.87

Coronary perivascular adipose tissue characteristics are related to atherosclerotic plaque size and composition. A post-mortem study. Atherosclerosis (2012) 0.87

Chronic cola drinking induces metabolic and cardiac alterations in rats. World J Cardiol (2011) 0.86

Ligation of macrophage Fcγ receptors recapitulates the gene expression pattern of vulnerable human carotid plaques. PLoS One (2011) 0.83

Metabolic disturbances and worsening of atherosclerotic lesions in ApoE-/- mice after cola beverages drinking. Cardiovasc Diabetol (2013) 0.83

Liver-artery interactions via the plasminogen-CD36 axis in macrophage foam cell formation: new evidence for the role of remote organ crosstalk in atherosclerosis. Circulation (2013) 0.82

Dietary patterns and nutrient intakes of 7-year-old children taking part in an atherosclerosis prevention project in Finland. J Am Diet Assoc (2002) 0.81

Pro-atherogenic effects of probucol in apo E-KO mice may be mediated through alterations in immune system: Parallel alterations in gene expression in the aorta and liver. Atherosclerosis (2009) 0.79

Dietary pattern, a modifiable risk factor that can be easily assessed for atherosclerosis vascular disease prevention in clinical practice. Public Health Nutr (2010) 0.78